Ad
related to: food and drug administration ph
Search results
Why Is Insmed (INSM) Stock Up 134% Today?
InvestorPlace· 6 days agoInsmed (NASDAQ:INSM) stock is rising higher on Tuesday after the company announced positive results from a Phase 3 clinical trial of brensocatib in...
Study shows effectiveness of updated COVID-19 vaccines wanes moderately over time, is lower against...
Medical Xpress· 4 days agoPublished in the New England Journal of Medicine, the study found that COVID-19 boosters targeting the XBB.1.5 subvariants were most effective one month after receiving one. After four weeks ...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...
The Woonsocket Call· 4 days ago(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration ...
Don’t Sweat It! The Best Deodorants for All-Day Protection
Vogue· 1 day agoNo matter what the best deodorant looks like for you—baking soda enthusiast, rollerball only, or the...
Neurocrine Biosciences Announces CEO Succession Plan
FOX 4 Kansas City· 6 days agoNeurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced that Kevin Gorman, Ph.D., will retire as Chief Executive Officer of Neurocrine on October 11, 2024. Kyle Gano, ...
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer - Jazz...
Benzinga· 6 days agoTarget Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ locally advanced or metastatic biliary tract
How PherDal’s At-Home Insemination Kit Helps People Conceive Safely
Forbes· 5 days agoAccording to Dr. Jennifer Hintzsche, CEO of PherDal Fertility Science, unexplained infertility...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with...
telegraphherald.com· 4 days agoThe positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy and safety of risankizumab in adults with moderately to severely
Shining light on sepsis: Novel device could allow early detection of deadly condition
Medical Xpress· 5 days agoThe doctor can then treat the patient, often with antibiotics and intravenous fluids, to try to...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 4 days agoBiogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for ...